Co-Targeting of the PI3K and RAS Pathways for the Treatment of Carcinoid Tumors

被引：0
|
作者：
Valentino, Joseph
Li, Jing
Kim, Ji Tae
Song, Jun
Mustain, W. C.
Weiss, Heidi L.
Anthony, Lowell
Townsend, Courtney M.
Evers, B. Mark
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S644 / S644
页数：1
相关论文
共 50 条
  • [31] Targeting PI3K
    Cantley, L.
    Lewis, C. Cantley
    CANCER RESEARCH, 2012, 72
  • [32] Activation of the oncogene ERG by the Ras/ERK and PI3K/AKT pathways
    Strittmatter, Brady G.
    Hollenhorst, Peter
    CANCER RESEARCH, 2019, 79 (13)
  • [33] Conjoined hyperactivation of the RAS and PI3K pathways in advanced GIST.
    Li, Bin
    Garcia, Cesar Serrano
    Marino-Enriquez, Adrian
    Grunewald, Susanne
    Wang, Yuexiang
    Bahri, Nacef
    Lauria, Alexandra
    Raut, Chandrajit P.
    George, Suzanne
    Demetri, George D.
    Hornick, Jason L.
    Broto, Javier Martin
    Heinrich, Michael C.
    Bauer, Sebastian
    Corless, Christopher L.
    Fletcher, Jonathan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [34] Co-targeting toll-like receptor and PI3K survival signaling pathways in stem-like castration resistant prostate cancer cells
    Oseni, Saheed Oluwasina
    Branly, Rolando
    Pavlovic, Mirjana
    Kumi-Diaka, James
    CANCER RESEARCH, 2018, 78 (13)
  • [35] Co-Targeting MAP Kinase and Pi3K-Akt-mTOR Pathways in Meningioma: Preclinical Study of Alpelisib and Trametinib
    Mondielli, Gregoire
    Mougel, Gregory
    Darriet, Florent
    Roche, Catherine
    Querdray, Adeline
    Lisbonis, Christophe
    Appay, Romain
    Dufour, Henry
    Chinot, Olivier
    Graillon, Thomas
    Barlier, Anne
    CANCERS, 2022, 14 (18)
  • [36] Targeting PI3K in neuroblastoma
    Spitzenberg, Volker
    Koenig, Christian
    Ulm, Susanne
    Marone, Romina
    Roepke, Luise
    Mueller, Joerg P.
    Gruen, Michael
    Bauer, Reinhard
    Rubio, Ignacio
    Wymann, Matthias Paul
    Voigt, Astrid
    Wetzker, Reinhard
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (12) : 1881 - 1890
  • [37] Targeting PI3K in neuroblastoma
    Volker Spitzenberg
    Christian König
    Susanne Ulm
    Romina Marone
    Luise Röpke
    Jörg P. Müller
    Michael Grün
    Reinhard Bauer
    Ignacio Rubio
    Matthias Paul Wymann
    Astrid Voigt
    Reinhard Wetzker
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1881 - 1890
  • [38] JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: A rationale for co-targeting these pathways in metastatic breast cancer
    Britschgi, Adrian
    Andraos, Rita
    Brinkhaus, Heike
    Klebba, Inna
    Murakami, Masato
    Romanet, Vincent
    Mueller, Urs
    Radimerski, Thomas
    Bentires-Alj, Mohamed
    CANCER RESEARCH, 2013, 73 (08)
  • [39] Mutations in the RAS and PI3K Pathways are Associated With Metastatic Location in Colorectal Cancers
    Lan, Yuan-Tzu
    Jen-Kou, Lin
    Lin, Chien-Hsing
    Yang, Shung-Haur
    Lin, Chun-Chi
    Wang, Huann-Sheng
    Chen, Wei-Shone
    Lin, Tzu-Chen
    Jiang, Jeng-Kai
    Chang, Shih-Ching
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (07) : 905 - 910
  • [40] Ras, Erk, and PI3K signaling pathways in the central selection of B cells
    Greaves, Sarah A.
    Babolin, Chiara
    Torres, Raul M.
    Pelanda, Roberta
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
12345